Search

You searched for "Supporting"

2038 results found

Take this waltz

1 June 2016 | | EYE - Oculoplastic, EYE - Orbit
My last weekend on-call was the busiest I can remember for a very long time. We were just completely swamped with patients. The weather was not too good that Saturday and it felt like every second inhabitant of our ocean...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

The symbolism of eyes in Halloween traditions and popular culture

31 October 2025 | | EYE - General
Halloween is a festival steeped in symbolism. Pumpkins, skeletons, ghosts and witches dominate the seasonal iconography, each representing broader cultural anxieties about death, darkness and the supernatural. Among these motifs, the eye, often depicted as glowing, disembodied or grotesquely exaggerated,...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

Survey reveals poor public awareness of dry eye disease

17 May 2021
A new survey has revealed how few people are aware of Dry Eye Disease, a debilitating and painful eye condition which affects one in four people in the UK.

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

14 December 2023 | SLT, DSLT, the eagle, Belkin, Glaucoma, Laser therapy, USA
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

Biotech Healthcare transforms lives through its CSR initiative, 'I See You'

10 March 2025 | industry, refractive, Quality of life, international, myopia
Biotech Healthcare, one of the fastest growing companies in the ophthalmic industry, continues to make a meaningful impact with its transformative Corporate Social Responsibility (CSR) initiative, 'I See You.' This program reflects the company’s mission of ‘Access to Innovation’ by...

Report: UKISCRS 2023

15 November 2023 | | UKISCRS, Cataract surgery, refractive surgeons, Gill Wood, London, Events, Conferences, 2023
An Eye News exclusive report of The 47th Annual Congress of the United Kingdom & Ireland Society of Cataract & Refractive Surgeons.

The most frequent complaints and claims in ophthalmology – a Medical Protection Society (MPS) analysis

4 December 2018 | | EYE - Cataract, EYE - Refractive, EYE - Glaucoma, EYE - General
The authors look at the reasons behind medico-legal cases reported to MPS and share key learning points. Complications following ophthalmology surgery are rare, however, medico-legal cases are not uncommon due to the significant impact they can have on patients’ lifestyles....

Diabetes macular oedema in pregnancy self-resolving postpartum

1 October 2021 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - General
*Equally contributing co-first authors. Diabetic macular oedema (DMO) is a common clinical presentation to ophthalmology clinics. Ample evidence exists for management of DMO in non-pregnant patients. However, there is a paucity of evidence on the optimal management of DMO in...

The ABC tragedies: Part one

2 October 2025 | | EYE - General
“In the midst of tragedy, we start the comedy” – Agatha Christie, The ABC Murders. Throughout a career in medicine, we are often faced with tragedy. One of the coping mechanisms is to use humour to navigate the mini everyday...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...